Global Platinum-based Anticancer Drugs Market Research Report 2021

Global Platinum-based Anticancer Drugs Market Research Report 2021

Table of Contents
1 Platinum-based Anticancer Drugs Market Overview
1.1 Product Overview and Scope of Platinum-based Anticancer Drugs
1.2 Platinum-based Anticancer Drugs Segment by Type
1.2.1 Global Platinum-based Anticancer Drugs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Cisplatin
1.2.3 Carboplatin
1.2.4 Oxaliplatin
1.2.5 Nedaplatin
1.2.6 Others
1.3 Platinum-based Anticancer Drugs Segment by Application
1.3.1 Platinum-based Anticancer Drugs Sales Comparison by Application: (2021-2027)
1.3.2 Testicular Cancer
1.3.3 Osteosarcoma
1.3.4 Breast Cancer
1.3.5 Esophageal Cancer
1.3.6 NSCLC
1.3.7 Other
1.4 Global Platinum-based Anticancer Drugs Market Size Estimates and Forecasts
1.4.1 Global Platinum-based Anticancer Drugs Revenue 2016-2027
1.4.2 Global Platinum-based Anticancer Drugs Sales 2016-2027
1.4.3 Platinum-based Anticancer Drugs Market Size by Region: 2016 Versus 2021 Versus 2027
2 Platinum-based Anticancer Drugs Market Competition by Manufacturers
2.1 Global Platinum-based Anticancer Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Platinum-based Anticancer Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Platinum-based Anticancer Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Platinum-based Anticancer Drugs Manufacturing Sites, Area Served, Product Type
2.5 Platinum-based Anticancer Drugs Market Competitive Situation and Trends
2.5.1 Platinum-based Anticancer Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Platinum-based Anticancer Drugs Players Market Share by Revenue
2.5.3 Global Platinum-based Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Platinum-based Anticancer Drugs Retrospective Market Scenario by Region
3.1 Global Platinum-based Anticancer Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Platinum-based Anticancer Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Platinum-based Anticancer Drugs Market Facts & Figures by Country
3.3.1 North America Platinum-based Anticancer Drugs Sales by Country
3.3.2 North America Platinum-based Anticancer Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Platinum-based Anticancer Drugs Market Facts & Figures by Country
3.4.1 Europe Platinum-based Anticancer Drugs Sales by Country
3.4.2 Europe Platinum-based Anticancer Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Platinum-based Anticancer Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Platinum-based Anticancer Drugs Sales by Region
3.5.2 Asia Pacific Platinum-based Anticancer Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Platinum-based Anticancer Drugs Market Facts & Figures by Country
3.6.1 Latin America Platinum-based Anticancer Drugs Sales by Country
3.6.2 Latin America Platinum-based Anticancer Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Platinum-based Anticancer Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Platinum-based Anticancer Drugs Sales by Country
3.7.2 Middle East and Africa Platinum-based Anticancer Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Platinum-based Anticancer Drugs Historic Market Analysis by Type
4.1 Global Platinum-based Anticancer Drugs Sales Market Share by Type (2016-2021)
4.2 Global Platinum-based Anticancer Drugs Revenue Market Share by Type (2016-2021)
4.3 Global Platinum-based Anticancer Drugs Price by Type (2016-2021)
5 Global Platinum-based Anticancer Drugs Historic Market Analysis by Application
5.1 Global Platinum-based Anticancer Drugs Sales Market Share by Application (2016-2021)
5.2 Global Platinum-based Anticancer Drugs Revenue Market Share by Application (2016-2021)
5.3 Global Platinum-based Anticancer Drugs Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Sanofi-Aventis
6.1.1 Sanofi-Aventis Corporation Information
6.1.2 Sanofi-Aventis Description and Business Overview
6.1.3 Sanofi-Aventis Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Sanofi-Aventis Product Portfolio
6.1.5 Sanofi-Aventis Recent Developments/Updates
6.2 Yakult honsha
6.2.1 Yakult honsha Corporation Information
6.2.2 Yakult honsha Description and Business Overview
6.2.3 Yakult honsha Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Yakult honsha Product Portfolio
6.2.5 Yakult honsha Recent Developments/Updates
6.3 Dr Reddy's laboratories
6.3.1 Dr Reddy's laboratories Corporation Information
6.3.2 Dr Reddy's laboratories Description and Business Overview
6.3.3 Dr Reddy's laboratories Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Dr Reddy's laboratories Product Portfolio
6.3.5 Dr Reddy's laboratories Recent Developments/Updates
6.4 Sun Pharmaceutical
6.4.1 Sun Pharmaceutical Corporation Information
6.4.2 Sun Pharmaceutical Description and Business Overview
6.4.3 Sun Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sun Pharmaceutical Product Portfolio
6.4.5 Sun Pharmaceutical Recent Developments/Updates
6.5 Teva
6.5.1 Teva Corporation Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Teva Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 Fresenius Kabi
6.6.1 Fresenius Kabi Corporation Information
6.6.2 Fresenius Kabi Description and Business Overview
6.6.3 Fresenius Kabi Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Fresenius Kabi Product Portfolio
6.6.5 Fresenius Kabi Recent Developments/Updates
6.7 Hospira(Pfizer)
6.6.1 Hospira(Pfizer) Corporation Information
6.6.2 Hospira(Pfizer) Description and Business Overview
6.6.3 Hospira(Pfizer) Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Hospira(Pfizer) Product Portfolio
6.7.5 Hospira(Pfizer) Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Corporation Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Mylan Product Portfolio
6.8.5 Mylan Recent Developments/Updates
6.9 Taj Pharmaceuticals
6.9.1 Taj Pharmaceuticals Corporation Information
6.9.2 Taj Pharmaceuticals Description and Business Overview
6.9.3 Taj Pharmaceuticals Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Taj Pharmaceuticals Product Portfolio
6.9.5 Taj Pharmaceuticals Recent Developments/Updates
6.10 Jiangsu Hengrui Medicine
6.10.1 Jiangsu Hengrui Medicine Corporation Information
6.10.2 Jiangsu Hengrui Medicine Description and Business Overview
6.10.3 Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Jiangsu Hengrui Medicine Product Portfolio
6.10.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.11 Nanjing Pharmaceutical Factory
6.11.1 Nanjing Pharmaceutical Factory Corporation Information
6.11.2 Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Description and Business Overview
6.11.3 Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Nanjing Pharmaceutical Factory Product Portfolio
6.11.5 Nanjing Pharmaceutical Factory Recent Developments/Updates
6.12 Jiangsu Aosaikang Pharmaceutical
6.12.1 Jiangsu Aosaikang Pharmaceutical Corporation Information
6.12.2 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Description and Business Overview
6.12.3 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Jiangsu Aosaikang Pharmaceutical Product Portfolio
6.12.5 Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
6.13 Qilu Pharmaceutical
6.13.1 Qilu Pharmaceutical Corporation Information
6.13.2 Qilu Pharmaceutical Platinum-based Anticancer Drugs Description and Business Overview
6.13.3 Qilu Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Qilu Pharmaceutical Product Portfolio
6.13.5 Qilu Pharmaceutical Recent Developments/Updates
6.14 Hisun Pharmaceutical
6.14.1 Hisun Pharmaceutical Corporation Information
6.14.2 Hisun Pharmaceutical Platinum-based Anticancer Drugs Description and Business Overview
6.14.3 Hisun Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Hisun Pharmaceutical Product Portfolio
6.14.5 Hisun Pharmaceutical Recent Developments/Updates
6.15 Luoxin
6.15.1 Luoxin Corporation Information
6.15.2 Luoxin Platinum-based Anticancer Drugs Description and Business Overview
6.15.3 Luoxin Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Luoxin Product Portfolio
6.15.5 Luoxin Recent Developments/Updates
6.16 Lingnan Pharmacy
6.16.1 Lingnan Pharmacy Corporation Information
6.16.2 Lingnan Pharmacy Platinum-based Anticancer Drugs Description and Business Overview
6.16.3 Lingnan Pharmacy Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Lingnan Pharmacy Product Portfolio
6.16.5 Lingnan Pharmacy Recent Developments/Updates
6.17 Hansoh Pharma
6.17.1 Hansoh Pharma Corporation Information
6.17.2 Hansoh Pharma Platinum-based Anticancer Drugs Description and Business Overview
6.17.3 Hansoh Pharma Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Hansoh Pharma Product Portfolio
6.17.5 Hansoh Pharma Recent Developments/Updates
7 Platinum-based Anticancer Drugs Manufacturing Cost Analysis
7.1 Platinum-based Anticancer Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Platinum-based Anticancer Drugs
7.4 Platinum-based Anticancer Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Platinum-based Anticancer Drugs Distributors List
8.3 Platinum-based Anticancer Drugs Customers
9 Platinum-based Anticancer Drugs Market Dynamics
9.1 Platinum-based Anticancer Drugs Industry Trends
9.2 Platinum-based Anticancer Drugs Growth Drivers
9.3 Platinum-based Anticancer Drugs Market Challenges
9.4 Platinum-based Anticancer Drugs Market Restraints
10 Global Market Forecast
10.1 Platinum-based Anticancer Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Platinum-based Anticancer Drugs by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Platinum-based Anticancer Drugs by Type (2022-2027)
10.2 Platinum-based Anticancer Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Platinum-based Anticancer Drugs by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Platinum-based Anticancer Drugs by Application (2022-2027)
10.3 Platinum-based Anticancer Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Platinum-based Anticancer Drugs by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Platinum-based Anticancer Drugs by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Platinum-based Anticancer Drugs Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Platinum-based Anticancer Drugs Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Platinum-based Anticancer Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Platinum-based Anticancer Drugs Covered in This Study
Table 5. Global Platinum-based Anticancer Drugs Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Platinum-based Anticancer Drugs Sales Share by Manufacturers (2016-2021)
Table 7. Global Platinum-based Anticancer Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Platinum-based Anticancer Drugs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Platinum-based Anticancer Drugs Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Platinum-based Anticancer Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Platinum-based Anticancer Drugs Product Type
Table 12. Global Platinum-based Anticancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Platinum-based Anticancer Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Platinum-based Anticancer Drugs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Platinum-based Anticancer Drugs Sales by Region (2016-2021) & (K Units)
Table 16. Global Platinum-based Anticancer Drugs Sales Market Share by Region (2016-2021)
Table 17. Global Platinum-based Anticancer Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Platinum-based Anticancer Drugs Sales by Country (2016-2021) & (K Units)
Table 19. North America Platinum-based Anticancer Drugs Sales Market Share by Country (2016-2021)
Table 20. North America Platinum-based Anticancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Platinum-based Anticancer Drugs Revenue Market Share by Country (2016-2021)
Table 22. Europe Platinum-based Anticancer Drugs Sales by Country (2016-2021) & (K Units)
Table 23. Europe Platinum-based Anticancer Drugs Sales Market Share by Country (2016-2021)
Table 24. Europe Platinum-based Anticancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Platinum-based Anticancer Drugs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Platinum-based Anticancer Drugs Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Platinum-based Anticancer Drugs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Platinum-based Anticancer Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Platinum-based Anticancer Drugs Revenue Market Share by Region (2016-2021)
Table 30. Latin America Platinum-based Anticancer Drugs Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Platinum-based Anticancer Drugs Sales Market Share by Country (2016-2021)
Table 32. Latin America Platinum-based Anticancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Platinum-based Anticancer Drugs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Platinum-based Anticancer Drugs Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Platinum-based Anticancer Drugs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Platinum-based Anticancer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Platinum-based Anticancer Drugs Revenue Market Share by Country (2016-2021)
Table 38. Global Platinum-based Anticancer Drugs Sales (K Units) by Type (2016-2021)
Table 39. Global Platinum-based Anticancer Drugs Sales Market Share by Type (2016-2021)
Table 40. Global Platinum-based Anticancer Drugs Revenue (Million US$) by Type (2016-2021)
Table 41. Global Platinum-based Anticancer Drugs Revenue Share by Type (2016-2021)
Table 42. Global Platinum-based Anticancer Drugs Price (US$/Unit) by Type (2016-2021)
Table 43. Global Platinum-based Anticancer Drugs Sales (K Units) by Application (2016-2021)
Table 44. Global Platinum-based Anticancer Drugs Sales Market Share by Application (2016-2021)
Table 45. Global Platinum-based Anticancer Drugs Revenue (Million US$) by Application (2016-2021)
Table 46. Global Platinum-based Anticancer Drugs Revenue Share by Application (2016-2021)
Table 47. Global Platinum-based Anticancer Drugs Price (US$/Unit) by Application (2016-2021)
Table 48. Sanofi-Aventis Corporation Information
Table 49. Sanofi-Aventis Description and Business Overview
Table 50. Sanofi-Aventis Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Sanofi-Aventis Platinum-based Anticancer Drugs Product
Table 52. Sanofi-Aventis Recent Developments/Updates
Table 53. Yakult honsha Corporation Information
Table 54. Yakult honsha Description and Business Overview
Table 55. Yakult honsha Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Yakult honsha Platinum-based Anticancer Drugs Product
Table 57. Yakult honsha Recent Developments/Updates
Table 58. Dr Reddy's laboratories Corporation Information
Table 59. Dr Reddy's laboratories Description and Business Overview
Table 60. Dr Reddy's laboratories Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Dr Reddy's laboratories Platinum-based Anticancer Drugs Product
Table 62. Dr Reddy's laboratories Recent Developments/Updates
Table 63. Sun Pharmaceutical Corporation Information
Table 64. Sun Pharmaceutical Description and Business Overview
Table 65. Sun Pharmaceutical Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Sun Pharmaceutical Platinum-based Anticancer Drugs Product
Table 67. Sun Pharmaceutical Recent Developments/Updates
Table 68. Teva Corporation Information
Table 69. Teva Description and Business Overview
Table 70. Teva Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Teva Platinum-based Anticancer Drugs Product
Table 72. Teva Recent Developments/Updates
Table 73. Fresenius Kabi Corporation Information
Table 74. Fresenius Kabi Description and Business Overview
Table 75. Fresenius Kabi Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Fresenius Kabi Platinum-based Anticancer Drugs Product
Table 77. Fresenius Kabi Recent Developments/Updates
Table 78. Hospira(Pfizer) Corporation Information
Table 79. Hospira(Pfizer) Description and Business Overview
Table 80. Hospira(Pfizer) Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Hospira(Pfizer) Platinum-based Anticancer Drugs Product
Table 82. Hospira(Pfizer) Recent Developments/Updates
Table 83. Mylan Corporation Information
Table 84. Mylan Description and Business Overview
Table 85. Mylan Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Mylan Platinum-based Anticancer Drugs Product
Table 87. Mylan Recent Developments/Updates
Table 88. Taj Pharmaceuticals Corporation Information
Table 89. Taj Pharmaceuticals Description and Business Overview
Table 90. Taj Pharmaceuticals Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Taj Pharmaceuticals Platinum-based Anticancer Drugs Product
Table 92. Taj Pharmaceuticals Recent Developments/Updates
Table 93. Jiangsu Hengrui Medicine Corporation Information
Table 94. Jiangsu Hengrui Medicine Description and Business Overview
Table 95. Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Product
Table 97. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 98. Nanjing Pharmaceutical Factory Corporation Information
Table 99. Nanjing Pharmaceutical Factory Description and Business Overview
Table 100. Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Product
Table 102. Nanjing Pharmaceutical Factory Recent Developments/Updates
Table 103. Jiangsu Aosaikang Pharmaceutical Corporation Information
Table 104. Jiangsu Aosaikang Pharmaceutical Description and Business Overview
Table 105. Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Product
Table 107. Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
Table 108. Qilu Pharmaceutical Corporation Information
Table 109. Qilu Pharmaceutical Description and Business Overview
Table 110. Qilu Pharmaceutical Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Qilu Pharmaceutical Platinum-based Anticancer Drugs Product
Table 112. Qilu Pharmaceutical Recent Developments/Updates
Table 113. Hisun Pharmaceutical Corporation Information
Table 114. Hisun Pharmaceutical Description and Business Overview
Table 115. Hisun Pharmaceutical Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Hisun Pharmaceutical Platinum-based Anticancer Drugs Product
Table 117. Hisun Pharmaceutical Recent Developments/Updates
Table 118. Luoxin Corporation Information
Table 119. Luoxin Description and Business Overview
Table 120. Luoxin Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Luoxin Platinum-based Anticancer Drugs Product
Table 122. Luoxin Recent Developments/Updates
Table 123. Lingnan Pharmacy Corporation Information
Table 124. Lingnan Pharmacy Description and Business Overview
Table 125. Lingnan Pharmacy Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. Lingnan Pharmacy Platinum-based Anticancer Drugs Product
Table 127. Lingnan Pharmacy Recent Developments/Updates
Table 128. Hansoh Pharma Corporation Information
Table 129. Hansoh Pharma Description and Business Overview
Table 130. Hansoh Pharma Platinum-based Anticancer Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. Hansoh Pharma Platinum-based Anticancer Drugs Product
Table 132. Hansoh Pharma Recent Developments/Updates
Table 133. Production Base and Market Concentration Rate of Raw Material
Table 134. Key Suppliers of Raw Materials
Table 135. Platinum-based Anticancer Drugs Distributors List
Table 136. Platinum-based Anticancer Drugs Customers List
Table 137. Platinum-based Anticancer Drugs Market Trends
Table 138. Platinum-based Anticancer Drugs Growth Drivers
Table 139. Platinum-based Anticancer Drugs Market Restraints
Table 140. Global Platinum-based Anticancer Drugs Sales Forecast by Type (2022-2027) & (K Units)
Table 141. Global Platinum-based Anticancer Drugs Sales Market Share Forecast by Type (2022-2027)
Table 142. Global Platinum-based Anticancer Drugs Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 143. Global Platinum-based Anticancer Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 144. Global Platinum-based Anticancer Drugs Sales Forecast by Application (2022-2027) & (K Units)
Table 145. Global Platinum-based Anticancer Drugs Sales Market Share Forecast by Application (2022-2027)
Table 146. Global Platinum-based Anticancer Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 147. Global Platinum-based Anticancer Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 148. Global Platinum-based Anticancer Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 149. Global Platinum-based Anticancer Drugs Sales Market Share Forecast by Region (2022-2027)
Table 150. Global Platinum-based Anticancer Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 151. Global Platinum-based Anticancer Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Platinum-based Anticancer Drugs
Figure 2. Global Platinum-based Anticancer Drugs Market Share by Type in 2020 & 2027
Figure 3. Cisplatin Product Picture
Figure 4. Carboplatin Product Picture
Figure 5. Oxaliplatin Product Picture
Figure 6. Nedaplatin Product Picture
Figure 7. Others Product Picture
Figure 8. Global Platinum-based Anticancer Drugs Market Share by Application in 2020 & 2027
Figure 9. Testicular Cancer
Figure 10. Osteosarcoma
Figure 11. Breast Cancer
Figure 12. Esophageal Cancer
Figure 13. NSCLC
Figure 14. Other
Figure 15. Global Platinum-based Anticancer Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Platinum-based Anticancer Drugs Market Size 2016-2027 (US$ Million)
Figure 17. Global Platinum-based Anticancer Drugs Sales 2016-2027 (K Units)
Figure 18. Global Platinum-based Anticancer Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 19. Platinum-based Anticancer Drugs Sales Share by Manufacturers in 2020
Figure 20. Global Platinum-based Anticancer Drugs Revenue Share by Manufacturers in 2020
Figure 21. The Global 5 and 10 Largest Platinum-based Anticancer Drugs Players: Market Share by Revenue in 2020
Figure 22. Platinum-based Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 23. Global Platinum-based Anticancer Drugs Sales Market Share by Region (2016-2021)
Figure 24. Global Platinum-based Anticancer Drugs Sales Market Share by Region in 2020
Figure 25. Global Platinum-based Anticancer Drugs Revenue Market Share by Region (2016-2021)
Figure 26. Global Platinum-based Anticancer Drugs Revenue Market Share by Region in 2020
Figure 27. U.S. Platinum-based Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Canada Platinum-based Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Germany Platinum-based Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. France Platinum-based Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. U.K. Platinum-based Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Italy Platinum-based Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Russia Platinum-based Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. China Platinum-based Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Japan Platinum-based Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. South Korea Platinum-based Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. India Platinum-based Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Australia Platinum-based Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Taiwan Platinum-based Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Indonesia Platinum-based Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Thailand Platinum-based Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Malaysia Platinum-based Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Philippines Platinum-based Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Vietnam Platinum-based Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Mexico Platinum-based Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Brazil Platinum-based Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Argentina Platinum-based Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Turkey Platinum-based Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Saudi Arabia Platinum-based Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. UAE Platinum-based Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. Sales Market Share of Platinum-based Anticancer Drugs by Type (2016-2021)
Figure 52. Sales Market Share of Platinum-based Anticancer Drugs by Application (2016-2021)
Figure 53. Sales Market Share of Platinum-based Anticancer Drugs by Application in 2020
Figure 54. Revenue Share of Platinum-based Anticancer Drugs by Application (2016-2021)
Figure 55. Revenue Share of Platinum-based Anticancer Drugs by Application in 2020
Figure 56. Manufacturing Cost Structure of Platinum-based Anticancer Drugs
Figure 57. Manufacturing Process Analysis of Platinum-based Anticancer Drugs
Figure 58. Platinum-based Anticancer Drugs Industrial Chain Analysis
Figure 59. Channels of Distribution
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs